Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect N gene, RdRP gene and S gene for SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.

  • Dual whole process controls
  • Short TAT (4 hours) from extraction to the final results
  • Detection and differentiation of essential 7 viruses causing respiratory tract infections in a single reaction
  • Providing the endogenous internal control in order to validate correct sampling for self-collected specimens
  • PCR with high sensitivity and specificity
  • Accurate test results allow to quick and proper treatment

The Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay for Detecting SARS-CoV-2 for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Atellica® IM SARS-CoV-2 IgG (sCOVG) assay for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Atellica® IM SARS-CoV-2 IgG (sCOVG) assay for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top